The Fibrous Dysplasia/McCune Albright International Consortium issued guidelines to the effect that all such patients should be monitored using the nuclear medicine-based fibrous dysplasia score.
As such, the ESPR MSK Taskforce would be very grateful if you could spare 10 minutes to complete this survey, which is intended to ascertain knowledge and use of the score amongst our membership.
The deadline for completion is Monday 4th April 2022.

Help us with your experience and feedback!

Access the survey